SCHEDULE: Vanguard Discloses 5.16% Stake in Teladoc Health

Vanguard Capital Management has reported beneficial ownership of 9,205,306 shares, representing 5.16% of Teladoc Health's common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, now beneficially owns 9,205,306 shares of Teladoc Health Inc. common stock.
• This holding represents 5.16% of the total class of securities.
• The filing indicates sole dispositive power over 9,205,306 shares and sole voting power over 1,348,137 shares.
• The reporting date for this ownership stake is March 31, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive indicator, reflecting a major institutional investor's passive stake, which suggests a baseline level of confidence without implying active engagement or immediate strategic shifts.

Positives

• Vanguard's significant stake suggests confidence in Teladoc Health's long-term prospects from a major institutional investor.
• The clear disclosure of ownership provides transparency to the market regarding a substantial shareholder.

Future Outlook

This filing is a Schedule 13G, which reports passive ownership stakes and does not contain forward-looking statements or guidance from the company itself. Vanguard's investment reflects their assessment of the company's value.

Industry Context

StockSavvy.ai notes that a significant stake by a large asset manager like Vanguard in a telehealth company like Teladoc Health indicates continued institutional interest in the digital health sector, despite potential market volatility and competitive pressures.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant institutional holder, which can influence market perception and potentially attract further investment.
• Management: The presence of a large passive investor like Vanguard may encourage continued focus on long-term value creation and governance.

Key Dates

Keywords

Teladoc Health, Vanguard Capital Management, Schedule 13G, SEC Filing, Beneficial Ownership, Common Stock, Institutional Investor, Telehealth